MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0087433
Ajmera Pharmasure Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.52 Cr
▼ 44% YoY
Net profit · FY 2025
₹94.12 Lakh
Net margin 3.5%
EBITDA · FY 2025
₹98.68 Lakh
EBITDA margin 3.7%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹5.53 Cr
Issued & subscribed
Open charges
₹30.5 Cr
Satisfied ₹12.9 Cr
Company age
36 yrs
Est. 1990
Directors on board
3
As per MCA filings
About Ajmera Pharmasure Limited
Data last updated:
Ajmera Pharmasure Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 May 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51109MH1990PLC056421. Its GSTIN is 27AAACA3801C1ZF (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.53 Cr. It was formerly known as Ajmera Trading and Impex Private Limited and Ajmera Pharmasure Private Limited. It is led by directors including Manish Kishore Ajmera (Whole-Time Director) and Rajveer Ashish Ajmera.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 4th Floor Ajmera House Pathakwadi, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.52 Cr, a decline of 44% compared to the previous year. For the same year it recorded a net profit of ₹94.12 Lakh (net margin 3.5%) and EBITDA of ₹98.68 Lakh (EBITDA margin 3.7%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 24% over five years.
Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹30.5 Cr and satisfied charges of ₹12.9 Cr on record. Court records list 6 cases involving the company, including 4 filed by the company and 2 filed against it; 2 cases are pending. The company has 12 deals on record (11 secondary share transfers, 1 funding round), with disclosed funding of ₹53 Lakh; the latest was in March 2023. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is K Kyemistry (India) Private Limited with revenue of ₹26.66 Cr.
Ajmera Pharmasure Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0087433). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ajmera.co.in.
Company details
CIN U51109MH1990PLC056421
Registration Number 056421
Incorporation Date 04 May 1990
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0087433
Name history
Ajmera Pharmasure has undergone 2 name changes throughout its history. The company was previously known as Ajmera Trading And Impex Private Limited, and Ajmera Pharmasure Private Limited. The current legal name is Ajmera Pharmasure Limited.
| Company Name | Status |
|---|---|
| Ajmera Pharmasure Limited | Current |
| Ajmera Trading And Impex Private Limited | Previous |
| Ajmera Pharmasure Private Limited | Previous |
CIN history
Ajmera Pharmasure has one previous CIN (Corporate Identification Number): U51109MH1990PTC056421. The current CIN is U51109MH1990PLC056421, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51109MH1990PLC056421 | Current |
| U51109MH1990PTC056421 | Previous |
Key People
Manish Kishore Ajmera Whole-Time Director Rajveer Ashish Ajmera Director Jash Alpesh Ajmera Director Recognitions & Rankings of Ajmera Pharmasure
Contact details
Ajmera Pharmasure Limited's registered office is in Mumbai, Maharashtra. Its website is ajmera.co.in. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address4th Floor Ajmera House Pathakwadi, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ajmera Pharmasure Limited, buy the company report.
Comprehensive company report
Ajmera Pharmasure Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ajmera Pharmasure is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ajmera Pharmasure Limited, buy the company report.
Financials of Ajmera Pharmasure Limited
FY 2024 filings availableAjmera Pharmasure Limited reported revenue of ₹26.52 Cr (down 44% YoY) for FY 2025.
Revenue · FY 2025
₹26.52 Cr ▼ 44%
Net profit · FY 2025
₹94.12 Lakh margin 3.5%
EBITDA · FY 2025
₹98.68 Lakh margin 3.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 44%
3 years · compounded
▼ 29%
5 years · compounded
▼ 24%
EBITDA CAGR growth
1 year
▲ 124%
3 years · compounded
▼ 25%
5 years · compounded
▼ 26%
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 44% fall in the latest year. EBITDA rose 124% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹98.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹94.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ajmera Pharmasure Limited, buy the company report.
Board of directors of Ajmera Pharmasure Limited
Ajmera Pharmasure has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajveer Ashish Ajmera | Director | 17 Jan 2023 | 3 Years 9 Months | Current |
| Jash Alpesh Ajmera Also directs: Ajmera Human Resource LLP, Wisteria Buildcon Private Limited | Director | 30 Jun 2022 | 4 Years 4 Months | Current |
| Manish Kishore Ajmera | Whole-Time Director | 04 May 1990 | 36 Years 6 Months | Current |
Peer comparison
Ajmera Pharmasure Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| K Kyemistry (India) Private Limited | ₹26.66 Cr (FY 2024) | 1.0% | Ahmedabad, Gujarat, India | |||
| K G Life Science Private Limited | ₹26.62 Cr (FY 2025) | -9.0% | Ahmedabad, Gujarat, India | |||
| Sparsh Remedies Private Limited | ₹26.54 Cr (FY 2024) | 13.0% | Mumbai, Maharashtra, India | |||
| Ajmera Pharmasure Limitedthis company | ₹26.52 Cr (FY 2025) | ₹94.12 Lakh | 3.5% | -44.0% | Mumbai, Maharashtra, India | |
| Triton Health Care Private Limited | ₹26.38 Cr (FY 2025) | 1.0% | Chennai, Tamil Nadu, India | |||
| Satyam Medical Agency Private Limited | ₹26.29 Cr (FY 2025) | 79.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Ajmera Pharmasure Limited, buy the company report.
Auditor
Ajmera Pharmasure Limited is audited by Kailas Yadu Shinare for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kailas Yadu Shinare | FY 2023 | 152633 |
Shareholding
The shareholding of Ajmera Pharmasure Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ajmera Pharmasure Limited, buy the company report.
Charges & borrowings
Open charges
₹30.5 Cr
Satisfied charges
₹12.9 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Apr 2017 | 100092848 | Hdfc Bank Limited | ₹20 Cr | Open | |
| 03 Apr 2017 | 100094239 | Hdfc Bank Limited | ₹8 Cr | Open | |
| 30 Mar 2016 | 100018937 | Others | ₹2.5 Cr | Open | |
| 23 Nov 2009 | 10192059 | Union Bank of India | ₹10.5 Cr | Satisfied | |
| 02 Feb 2008 | 10093915 | Icici Bank Limited | ₹2 Cr | Satisfied |
To see the full charge records of Ajmera Pharmasure Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Ajmera Pharmasure Limited has 12 deals on record (11 secondary share transfers, 1 funding round), with disclosed funding of ₹53 Lakh; the latest was in March 2023.
Total deals
12
Secondary share transfers
11
Funding round
1
Disclosed funding
₹53 Lakh
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: Jiten K Ajmera Huf, 3 individuals Seller: Jasmin Ajemra Huf, 3 individuals |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Jesal M. Ajmera Huf, Manharlal H Ajmera Huf |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Kishor H. Ajmera Huf, 3 individuals Seller: Pankaj Manharlal Ajmera Huf, Manharlal H Ajmera Huf, 2 individuals |
| Dec 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Richie Rich Resorts Private Limited |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Jayesh Manharlal Ajmera Huf, 3 individuals |
To see the full deal history of Ajmera Pharmasure Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ajmera Pharmasure Limited has 6 court cases on record: 4 filed by Ajmera Pharmasure, 2 filed against it. 2 cases are pending and 4 are disposed.
Total cases
6
Filed by the company
4
Filed against the company
2
Pending
2
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 2 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Dipna Pharmachem Limited and 4 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Shibani Nexus Pvt Ltd and Ors and 2 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against 1. Ms. Cecil Pharmaceuticals P Ltd. Ors | Disposed |
| High Court | Tax appeal | Filed against the company by PR Commissioner of Income Tax 4 | Disposed |
| High Court | Interim or miscellaneous application | Filed against the company by Pr.Commissioner of Income Tax 4 | Disposed |
To see the full case history of Ajmera Pharmasure Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Ajmera Pharmasure Limited was last rated by Care on 08 Feb 2017.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 08 Feb 2017 |
To see the full credit ratings and regulatory alerts of Ajmera Pharmasure Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ajmera Pharmasure Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Ajmera Pharmasure has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Ajmera Organics Private Limited | U24119MH2002PTC134397 |
To see the full group structure of Ajmera Pharmasure Limited, buy the company report.
GST
Ajmera Pharmasure has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA3801C1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ajmera Pharmasure Limited, buy the company report.
Recent activity
Ajmera Pharmasure Limited has 10 board changes on record since 1990: 3 appointments and 7 cessations. The latest: Rajveer Ashish Ajmera was appointed as Director on 17 Jan 2023.
AGM
Ajmera Pharmasure Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ajmera Pharmasure Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Rajveer Ashish Ajmera was appointed as Director.
Appointed
Jash Alpesh Ajmera was appointed as Director.
Ceased
Minal Manish Ajmera ceased to be Director.
Charges
A charge with Hdfc Bank Limited of Rs. 8.00 Cr registered on 03 Apr 2017 with Charge ID 100094239 was modified on 04 Feb 2021.
Charges
A charge with Hdfc Bank Limited of Rs. 20.00 Cr registered on 06 Apr 2017 with Charge ID 100092848 was modified on 26 Feb 2019.
Ceased
Deepak Bhogilal Shah ceased to be Director.
Charges
A charge registered on 23 Nov 2009 via Charge ID 10192059 with Union Bank Of India was fully satisfied on 19 May 2017.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.00 Cr with Charge ID 100092848 was registered on 06 Apr 2017.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.00 Cr with Charge ID 100094239 was registered on 03 Apr 2017.
Ceased
Utpal Ramanlal Desai ceased to be Director.
13 earlier events are in the company report.
Frequently asked questions
Ajmera Pharmasure is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 May 1990 (36+ years old) and is registered under CIN U51109MH1990PLC056421.
Ajmera Pharmasure has 3 current directors:
- Manish Kishore Ajmera - Whole-Time Director
- Rajveer Ashish Ajmera - Director
- Jash Alpesh Ajmera - Director
The latest financial statements of Ajmera Pharmasure on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ajmera Pharmasure is 27AAACA3801C1ZF, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ajmera Pharmasure is U51109MH1990PLC056421. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ajmera Pharmasure has 6 court cases on record: 4 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Ajmera Pharmasure was incorporated on 04 May 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
Ajmera Pharmasure has 12 deals on record (11 secondary share transfers, 1 funding round), with disclosed funding of ₹53 Lakh; the latest was in March 2023.
The peers of Ajmera Pharmasure by revenue are K Kyemistry (India) Private Limited, K G Life Science Private Limited, Sparsh Remedies Private Limited, Triton Health Care Private Limited, Satyam Medical Agency Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rajveer Ashish Ajmera was appointed as Director on 17 Jan 2023. Jash Alpesh Ajmera was appointed as Director on 30 Jun 2022. Minal Manish Ajmera ceased to be Director on 30 Jun 2022. Ajmera Pharmasure has 10 board changes on record in total.
Yes, Ajmera Pharmasure is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0087433).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages